Aptose Biosciences Inc. 3 SEC Filings

Filed On	Filing
20 Mar 2025	Form 3: Hanmi Pharmaceutical Co., Ltd., 10% owner Holds 508,710 shares of Common Shares
16 Sep 2022	Form 3: Seizinger Bernd R., Director No securities owned
28 Jun 2022	Form 3: Payne Fletcher, SR VP & Chief Fin. Officer No securities owned
14 Apr 2022	Form 3: Ledru Philippe, Chief Commercial Officer Holds 500 shares of Common Shares
05 Aug 2021	Form 3: Wilson Donald R. Jr., 10% owner and 2 others Holds 4,162 shares of Common Stock
03 Jan 2020	Form 3: Bejar Rafael, Chief Medical Officer No securities owned
05 Jun 2019	Form 3: Marango Jotin, Senior VP, Chief Bus. Officer No securities owned
21 Dec 2018	Form 3: Whitehead Warren, Director Holds 50,000 shares of Common Shares
21 Dec 2018	Form 3: Vincent Mark D., Director Holds 6,500 shares of Common Shares
21 Dec 2018	Form 3: Rice William G., Director Holds 133,014 shares of Common Shares
21 Dec 2018	Form 3: Platzer Erich, Director Holds 115,000 shares of Common Shares
21 Dec 2018	Form 3: Loewy Caroline M, Director
21 Dec 2018	Form 3: Chow Gregory K., Senior VP & CFO Holds 112,014 shares of Common Shares
21 Dec 2018	Form 3: Burger Denis R, Director Holds 16,254 shares of Common Shares
21 Dec 2018	Form 3: Ashe Carol Gail, Director

Comments